Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 1/20 | 0.54 |
| ▸ | NPC1 | O15118 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.48 |
| ▸ | MEN1 | O00255 | 3/20 | 0.48 |
| ▸ | HPGD | P15428 | 2/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | ITGB3 | P05106 | 2/20 | 0.47 |
| ▸ | ITGA2B | P08514 | 2/20 | 0.47 |
| ▸ | GNAI3 | P08754 | 3/20 | 0.46 |
| ▸ | GNAO1 | P09471 | 3/20 | 0.46 |
| ▸ | GNAI1 | P63096 | 3/20 | 0.46 |
| ▸ | GLA | P06280 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.45 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28400652 | 0.94 | GNAI3 (0.53) | ATMNPC1KMT2AALDH1A1MEN1 | |
| SCHEMBL10883612 | 0.94 | GNAI3 (0.53) | ATMNPC1KMT2AALDH1A1MEN1 | |
| SCHEMBL3242393 | 0.88 | SMN1; SMN2 (0.51) | KMT2AALDH1A1MEN1HPGDSMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL27078195 | 0.86 | SMN1; SMN2 (0.50) | KMT2AALDH1A1MEN1HPGDSMN1; SMN2 | |
| SCHEMBL6493498 | 0.84 | ATM (0.54) | ATMNPC1KMT2AALDH1A1MEN1 | |
| Hydrochloric Acid SCHEMBL28396748 | 0.83 | ATM (0.48) | ATMNPC1KMT2AALDH1A1MEN1 | |
| SCHEMBL5605766 | 0.82 | L3MBTL1 (0.49) | ATMNPC1KMT2AALDH1A1MEN1 | |
| SCHEMBL11240 | 0.82 | L3MBTL1 (0.62) | ATMNPC1KMT2AALDH1A1MEN1 | |
| SCHEMBL6043354 | 0.82 | ATM (0.50) | ATMNPC1KMT2AALDH1A1MEN1 | |
| SCHEMBL2732315 | 0.82 | ATM (0.50) | ATMNPC1KMT2AALDH1A1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118957804-A | Novel composite antibacterial polyester fiber and preparation method thereof | 江苏恒科新材料有限公司 | 2024-11-15 | — | — | CN | claimed |
| CN-118957804-A | Novel composite antibacterial polyester fiber and preparation method thereof | 江苏恒科新材料有限公司 | 2024-11-15 | — | — | CN | disclosed |
| CN-111194306-B | Methods and processes for preparing KDM1A inhibitors | 伊美格生物科学公司 | 2023-05-16 | — | — | CN | disclosed |
| EP-3741357-A1 | AMPHIPHILIC POLYMER SYSTEMS | Universitätsspital Basel (CH) | 2020-11-25 | — | — | EP | disclosed |
| CN-111194306-A | Methods and processes for preparing KDM1A inhibitors | 伊美格生物科学公司 | 2020-05-22 | — | — | CN | disclosed |
| EP-3236936-B1 | AMPHIPHILIC POLYMER SYSTEMS | UNIV BASEL (CH) | 2020-02-19 | — | — | EP | disclosed |
| US-9790499-B2 | Functionally-modified oligonucleotides and subunits thereof | SAREPTA THERAPEUTICS, INC. (US) | 2017-10-17 | — | — | US | disclosed |
| US-9278987-B2 | Functionally-modified oligonucleotides and subunits thereof | SAREPTA THERAPEUTICS, INC. (US) | 2016-03-08 | — | — | US | disclosed |
| US-20140330006-A1 | FUNCTIONALLY-MODIFIED OLIGONUCLEOTIDES AND SUBUNITS THEREOF | SAREPTA THERAPEUTICS, INC. (US) | 2014-11-06 | — | — | US | disclosed |
| WO-2013074834-A1 | FUNCTIONALLY-MODIFIED OLIGONUCLEOTIDES AND SUBUNITS THEREOF | SAREPTA THERAPEUTICS, INC. (US) | 2013-05-23 | — | — | WO | disclosed |
| CN-100543032-C | Streptogramin derivatives, preparation method and compositions containing them | AVETIS PHARMA S A (FR) | 2009-09-23 | — | — | CN | disclosed |
| CN-1961878-A | Streptogramin derivatives, their preparation and compositions containing them | AVENTIS PHARMA SA (FR) | 2007-05-16 | — | — | CN | disclosed |
| US-7166594-B2 | Antibacterial activity | AVENTIS PHARMA S.A. (FR) | 2007-01-23 | — | — | US | disclosed |
| US-20030149004-A1 | Streptogramin derivatives, their preparation and compositions containing them | AVENTIS PHARMA S.A. | 2003-08-07 | — | — | US | disclosed |
| US-6569854-B1 | Virginamycins | AVENTIS PHARMA S.A. (FR) | 2003-05-27 | — | — | US | disclosed |
| CN-1358194-A | Streptogramin derivatives, preparation method and compositions containing them | AVETIS PHARMA S A (FR) | 2002-07-10 | — | — | CN | disclosed |
| EP-0499130-A1 | DC-89 derivatives | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1992-08-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140330006-A1 | FUNCTIONALLY-MODIFIED OLIGONUCLEOTIDES AND SUBUNITS THEREOF | RTCB, NSUN3, NSUN2 | ATM 3539/4885NPC1 3978/4885KMT2A 2877/4885 |
| US-20030149004-A1 | Streptogramin derivatives, their preparation and compositions containing them | MRPL21, ABHD5, APEH | ATM 2840/4885NPC1 2105/4885KMT2A 3790/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.